• Facebook
  • Instagram
  • Twitter

Get Support – Call 1-888-MITO-411

  • Shop
  • Events
  • Donate
MitoAction

MitoAction

Support, Education, Outreach and Advocacy for Children and Adults Living with Mitochondrial Disease

  • Mitochondrial Disease
    • About Mito
      • New Patient Kit
      • Types of Mitochondrial Diseases
      • Symptoms
      • Treatment
      • Mito FAQ’s
      • Mitochondrial Disease News
    • Diagnosis & Care
      • Diagnosing Mitochondrial Disease
      • Find a Mito Doctor
      • What is a Mito Cocktail?
      • Mito Sick Protocol
      • Clinical Trials & Studies
    • Day to Day with Mito
      • Living with Mitochondrial Disease
      • Care Management
      • Managing Your Energy
      • Traveling with Mito
      • Navigating COVID-19
    • For Medical Professionals
      • Mitochondrial Care Network
      • Monthly Expert Series
  • Fatty Acid Oxidation Disorders
    • About FAODs
      • Types of FAOD
      • Symptoms
      • Diagnosis
      • Treatment
    • FAOD Programs and Support
      • New Patient Kit
      • FAOD Support Calls
      • FAOD Experts Series
      • FAOD Resources
      • International Metabolic Conference
  • Programs & Support
    • Support
      • Mito411
      • MitoAction Memories
      • MitoPlaydates
      • MitoSocials
      • MitoChampions
      • Support Calls
      • Positive Peach Packages
    • Programs
      • Dalia’s Wish
      • Matthew Harty Camper Fund
      • Marcel’s Way Family Fund
      • MitoSantas
      • MyMito App
    • Education
      • Monthly Expert Series
      • Wondering Wednesdays
      • Energy In Action Podcast
      • Energy 4 Education
      • Patient Education Forums
      • International Metabolic Conference
    • Resources & Planning
      • Health Insurance
      • Disability Benefits
      • Mobility Devices
      • Vehicle Modification
      • Estate Planning
      • Medical Child Abuse
  • Join the Cause
    • Giving
      • Donate
      • Honor and Memorial Giving
      • Another Helping
      • Matching Gifts
      • Shop for MitoAction
      • Giving Tuesday – Ways to Give
    • Events
      • International Metabolic Conference
      • MitoAction Energy Walks
      • Sandra K. Russell Derby Day Benefit for Mito
      • Matthew Harty Camper Fund Events
    • Volunteer
      • Host a MitoSocial
      • Host a MitoPlaydate
      • Create a Fundraiser
      • MitoChampions
      • Share Your Ideas
    • Raise Your Voice
      • Take Legislative Action
      • Mitochondrial Disease Awareness Week
      • Light a Light
  • About Us
    • Contact Us
    • Connect on Social
    • Our Team
    • Meet Our Partners
    • Newsletter Signup
  • Show Search

SCAD: Short-Chain acyl-CoA Dehydrogenase Deficiency

Nov 4, 2022

  • General
  • Genetics
  • Frequency
  • Symptoms
  • Diagnosis
  • Treatment
  • Clinical Trials
  • Resources

General Info

Overview

Short-chain acyl-CoA dehydrogenase deficiency is a genetic condition where a person’s body cannot properly break down certain types of fats. This prevents the body from creating needed energy during times of stress, illness, fasting, and exercise, which can lead to medical symptoms. The body usually gets its energy by breaking down, or burning, fats and sugars. The SCAD defect creates a loss of function toward the end of fat metabolism. Fortunately, due to the enzyme position in the breakdown of fat, SCAD deficiency may lead to less severe symptoms or even no symptoms (asymptomatic). Your doctor will work with you to help you better understand what SCAD means for you

Alternative Names

SCAD deficiency

Genetics

Affected Genes

ACADS

Inheritance Type(s)
  • Autosomal recessive
Cause and Genetics

People usually have two copies of the ACADS gene, one inherited from each parent. SCAD deficiency occurs when there are changes in both copies of the ACADS gene (autosomal recessive inheritance). Someone who has a change in only one copy of the ACADS gene is called a carrier, and they usually do not have any medical symptoms. If both parents are carriers, there is a 1 in 4 chance with each pregnancy that their child will have SCAD deficiency.


There are two common changes in the ACADS gene. These changes still alter the way the ACADS protein works, but the protein made is usually still able to do its job well enough that the person with SCAD deficiency doesn’t get sick. Some rare changes in the ACADS gene cause more of an effect on protein function, but people with these changes rarely get sick from SCAD deficiency. There is one rare genetic change that can cause the biggest effect on the ACADS protein when combined with one of the common changes.

Frequency

Frequency (Global)

1:40,000 - 1:100,000

Frequency - More Information

SCAD deficiency occurs in babies around the world. Some sources say that approximately 1 in 40,000 to 1 in 100,000 babies have SCAD deficiency, while others report higher numbers.

Affected Biological Gender

Both Male and Female

Signs and Symptoms

Reports of people with SCAD deficiency that did have signs or symptoms included:

  • Poor muscle tone (hypotonia)
  • Muscle weakness/breakdown (myopathy) and storage of fat in muscles
  • Failure to thrive
  • A buildup of acid in the body that can cause nausea, vomiting, fast breathing and extreme tiredness (metabolic acidosis)
  • A buildup of acid in the body in newborns that causes increased muscle tone (hyperreflexia)
  • Coma from high levels of ammonia in the blood (hyperammonemic coma)

Unlike other FAODs, SCAD deficiency does not cause low blood sugar (hypoglycemia) or low ketones (hypoketosis).

Diagnosis

Most cases of SCAD deficiency are identified by routine newborn screening. If newborn screening is suggestive of SCAD deficiency, additional tests may be performed including:

  • Measuring biochemical markers in the blood or urine
  • Performing a genetic test to look for changes in the genes that cause FAODs

Many newborn screening programs do not report when a baby has high levels of butyrylcarnitine (a sign of SCAD deficiency) since most SCAD deficiency is not considered harmful (benign). High levels of butyrylcarnitine are still sometimes reported on newborn screening because this, along with high levels of ethylmalonic acid, can happen in other metabolic conditions besides SCAD deficiency. Children who have signs or symptoms of FAODs along with high levels of these metabolites may be referred for further testing to rule out other conditions.

Newborn Screening: Recommended Uniform Screening Panel (RUSP)

Yes

Treatment

Treatment and Management

Before beginning any treatment or therapy, please consult with your physician. Most people with SCAD deficiency do not require specific treatment for SCAD, but if symptoms do occur a patient/caregiver should contact their doctor.

Clinical Trials

For specific details on clinical trials visit the MitoAction Clinical Trial page or www.clinicaltrials.gov.

Resources

  • Short-chain acyl-CoA dehydrogenase deficiency – About the Disease – The National Institutes of Health
  • SCAD Deficiency | Fatty Acid Oxidation Disorders Diagnosis – The INFORM Network
  • Newborn screening information for short-chain acyl-CoA dehydrogenase deficiency | Baby’s First Test
  • What is Short-chain acyl-CoA dehydrogenase deficiency (SCADD)? – ThinkGenetic, Inc

Connecting with others impacted by a rare disease allows for vital information to be shared about day-to-day life, prevents isolation, and gives hope. Please contact MitoAction for peer support opportunities at 888-MITO-411 or email mito411@mitoaction.org.

Other resources we recommend are:

  • New Patient Kit for Mitochondrial Conditions
  • Planning for Emergencies
  • Monthly Expert Series
  • Energy in Action Podcast

Download this Fact Sheet

MitoAction does not provide medical advice, diagnosis, treatment, or legal advice. It is essential that all those living with or caring for someone with a Mitochondrial or FAOD disease have an emergency protocol letter. These letters, which are written and signed by a doctor, share details about prescribed treatment during crises and in emergency room settings. Always check with your doctor if you or your child has concerns as everyone may present with symptoms differently. Before beginning any treatment or therapy, please consult with your physician.

Last Updated: 11/15/2022

Upcoming
Events

View All
Oct 5
6:00 pm - 7:00 pm Event Series

CPEO & Me

Oct 6
12:00 pm - 1:00 pm

Expert Series: Ultra-Rare Mitochondrial Diseases: Development Challenges and Opportunities

Oct 6
1:15 pm - 2:15 pm

Weekly Support Call

View Calendar

Expert
Series

View All

Upcoming Presentations

Oct 6
12:00 pm - 1:00 pm

Expert Series: Ultra-Rare Mitochondrial Diseases: Development Challenges and Opportunities

Nov 1
7:00 pm - 8:00 pm

Expert Series: LCHADD Retinopathy Update: Moving Toward a Treatment

View Calendar

Last Presentation

Episode 2: Wondering Wednesdays: Ask the Genetic Counselor (February 22, 2023)
Presented August 28, 2023

P.O. Box 310
Novi, MI 48376
(888) 648-6228
info@mitoaction.org

  • Support
  • Resources
  • Donate
  • Events
  • Subscribe
©2023 MitoAction. All Rights Reserved. Website by ThinkGenetic, Inc.

Privacy Policy. Terms of Use.